Notchless is required for axial skeleton formation in mice.

PLoS One

Mouse Functional Genetics, Department of Developmental & Stem Cell Biology, Institut Pasteur, Paris, France; Centre National de la Recherche Scientifique, URA 2578, Institut Pasteur, Paris, France.

Published: January 2015


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Maintenance of cell survival is essential for proper embryonic development. In the mouse, Notchless homolog 1 (Drosophila) (Nle1) is instrumental for survival of cells of the inner cell mass upon implantation. Here, we analyze the function of Nle1 after implantation using the Meox2(tm1(cre)Sor) mouse that expresses the Cre recombinase specifically in the epiblast at E5.5. First, we find that NLE1 function is required in epiblast cells, as Nle1-deficient cells are rapidly eliminated. In this report, we also show that the Meox2(Cre) transgene is active in specific tissues during organogenesis. In particular, we detect high Cre expression in the vertebral column, ribs, limbs and tailbud. We took advantage of this dynamic expression profile to analyze the effects of inducing mosaic deletion of Nle1 in the embryo. We show that Nle1 deletion in this context, results in severe developmental anomalies leading to lethality at birth. Mutant embryos display multiple developmental defects in particular during axial skeletal formation. We also provide evidence that axial defects are due to an increase in apoptotic cell death in the somite at E9.5. These data demonstrate an essential role for Nle1 during organogenesis and in particular during axial development.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4038589PMC
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0098507PLOS

Publication Analysis

Top Keywords

nle1
6
notchless required
4
axial
4
required axial
4
axial skeleton
4
skeleton formation
4
formation mice
4
mice maintenance
4
maintenance cell
4
cell survival
4

Similar Publications

Leveraging diverse cell-death patterns to predict to predict prognosis and immunotherapy in hepatocellular carcinoma.

Discov Oncol

August 2025

Department of Hepatobiliary and Pancreatic Surgery, First Affiliated Hospital, School of Medicine, Zhejiang University, No.79, Qingchun Rd, Hangzhou, 310003, Zhejiang, China.

Background: Currently, liver hepatocellular carcinoma (LIHC) is characterized by high morbidity, rapid progression and early metastasis. Although many efforts have been made to improve the prognosis of LIHC, the situation is still dismal. Inability to initiate the process of programmed cell death (PCD) is closely associated with cancer progression, thus influencing patients' prognosis.

View Article and Find Full Text PDF

WD40 Protein NLE1 as a Novel Diagnostic Biomarker Promoting Hepatocellular Carcinoma Proliferation.

Clin Med Insights Oncol

July 2025

Department of Digestive Disease, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.

Background: Hepatocellular carcinoma (HCC) is associated with poor prognosis and high mortality. Notchless homolog 1 (NLE1) is an important WD40 protein. Although several studies have shown that NLE1 is dysregulated in cancer, the function in hepatocarcinogenesis remains unclear.

View Article and Find Full Text PDF

The assembly of ribosomal subunits, primarily occurring in the nucleolar and nuclear compartments, is a highly complex process crucial for cellular function. This study reveals the conservation of ribosome biogenesis between yeast and humans, illustrated by the structural similarities of ribosomal subunit intermediates. By using X-ray crystallography and cryo-EM, the interaction between the human AAA+ ATPase MDN1 and the 60S assembly factor NLE1 is compared with the yeast homologs Rea1 and Rsa4.

View Article and Find Full Text PDF

Objective: Somatic variants causing epilepsy are challenging to detect, as they are only present in a subset of brain cells (e.g., mosaic), resulting in low variant allele frequencies.

View Article and Find Full Text PDF

Targeting glioblastoma with a brain-penetrant drug that impairs brain tumor stem cells via NLE1-Notch1 complex.

Stem Cell Reports

November 2024

Department of Cellular and Molecular Medicine, Faculty of Medicine, University of Ottawa, 451 Smyth Road, Ottawa, ON K1H 8M5, Canada; University of Ottawa Brain and Mind Research Institute, 451 Smyth Road, Ottawa, ON K1H 8M5, Canada; Ottawa Institute of Systems Biology, University of Ottawa, 451 Smy

Article Synopsis
  • Brain tumor stem cells (BTSCs) are key players in glioblastoma growth and treatment resistance, making them critical targets for new therapies.
  • Edaravone is identified as an effective drug that inhibits BTSCs without harming non-cancerous neural stem cells, impacting essential gene functions involved in cell growth and repair.
  • In preclinical studies, edaravone not only slows down tumor development and enhances the effectiveness of radiation therapy but also improves survival rates in animal models, suggesting its potential in treating glioblastoma patients.
View Article and Find Full Text PDF